108 related articles for article (PubMed ID: 35868534)
1. Docetaxel resistance-derived LINC01085 contributes to the immunotherapy of hormone-independent prostate cancer by activating the STING/MAVS signaling pathway.
Zhang J; Li S; Zhang J; Zhang W; Jiang J; Wu H; Wu E; Feng Y; Yang L; Li Z
Cancer Lett; 2022 Oct; 545():215829. PubMed ID: 35868534
[TBL] [Abstract][Full Text] [Related]
2. Interleukin 6, a nuclear factor-kappaB target, predicts resistance to docetaxel in hormone-independent prostate cancer and nuclear factor-kappaB inhibition by PS-1145 enhances docetaxel antitumor activity.
Domingo-Domenech J; Oliva C; Rovira A; Codony-Servat J; Bosch M; Filella X; Montagut C; Tapia M; Campás C; Dang L; Rolfe M; Ross JS; Gascon P; Albanell J; Mellado B
Clin Cancer Res; 2006 Sep; 12(18):5578-86. PubMed ID: 17000695
[TBL] [Abstract][Full Text] [Related]
3. ATM/NEMO signaling modulates the expression of PD-L1 following docetaxel chemotherapy in prostate cancer.
Wang Z; Zhang X; Li W; Su Q; Huang Z; Zhang X; Chen H; Mo C; Huang B; Ou W; Chen J; Zhao G; Chen L; Shao L
J Immunother Cancer; 2021 Jul; 9(7):. PubMed ID: 34301812
[TBL] [Abstract][Full Text] [Related]
4. Acetyl-11-keto-β-boswellic acid suppresses docetaxel-resistant prostate cancer cells in vitro and in vivo by blocking Akt and Stat3 signaling, thus suppressing chemoresistant stem cell-like properties.
Liu YQ; Wang SK; Xu QQ; Yuan HQ; Guo YX; Wang Q; Kong F; Lin ZM; Sun DQ; Wang RM; Lou HX
Acta Pharmacol Sin; 2019 May; 40(5):689-698. PubMed ID: 30171201
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-3646 Contributes to Docetaxel Resistance in Human Breast Cancer Cells by GSK-3β/β-Catenin Signaling Pathway.
Zhang X; Zhong S; Xu Y; Yu D; Ma T; Chen L; Zhao Y; Chen X; Yang S; Wu Y; Tang J; Zhao J
PLoS One; 2016; 11(4):e0153194. PubMed ID: 27045586
[TBL] [Abstract][Full Text] [Related]
6. Reversal of docetaxel resistance in prostate cancer by Notch signaling inhibition.
Qiu S; Deng L; Bao Y; Jin K; Tu X; Li J; Liao X; Liu Z; Yang L; Wei Q
Anticancer Drugs; 2018 Oct; 29(9):871-879. PubMed ID: 29944470
[TBL] [Abstract][Full Text] [Related]
7. LncRNA LINC00184 promotes docetaxel resistance and immune escape via miR-105-5p/PD-L1 axis in prostate cancer.
Zhang W; Xin J; Lai J; Zhang W
Immunobiology; 2022 Jan; 227(1):152163. PubMed ID: 34896914
[TBL] [Abstract][Full Text] [Related]
8. TRIM9 short isoform preferentially promotes DNA and RNA virus-induced production of type I interferon by recruiting GSK3β to TBK1.
Qin Y; Liu Q; Tian S; Xie W; Cui J; Wang RF
Cell Res; 2016 May; 26(5):613-28. PubMed ID: 26915459
[TBL] [Abstract][Full Text] [Related]
9. THO Complex Subunit 7 Homolog Negatively Regulates Cellular Antiviral Response against RNA Viruses by Targeting TBK1.
He TS; Xie T; Li J; Yang YX; Li C; Wang W; Cao L; Rao H; Ju C; Xu LG
Viruses; 2019 Feb; 11(2):. PubMed ID: 30769920
[TBL] [Abstract][Full Text] [Related]
10. Tumor suppressor RKIP inhibits prostate cancer cell metastasis and sensitizes prostate cancer cells to docetaxel treatment.
Zhu CX; Li WZ; Guo YL; Chen L; Li GH; Yu JJ; Shu B; Peng S
Neoplasma; 2018; 65(2):228-233. PubMed ID: 29534584
[TBL] [Abstract][Full Text] [Related]
11. Mechanisms and pathways of innate immune activation and regulation in health and cancer.
Cui J; Chen Y; Wang HY; Wang RF
Hum Vaccin Immunother; 2014; 10(11):3270-85. PubMed ID: 25625930
[TBL] [Abstract][Full Text] [Related]
12. Glycogen synthase kinase 3β regulates IRF3 transcription factor-mediated antiviral response via activation of the kinase TBK1.
Lei CQ; Zhong B; Zhang Y; Zhang J; Wang S; Shu HB
Immunity; 2010 Dec; 33(6):878-89. PubMed ID: 21145761
[TBL] [Abstract][Full Text] [Related]
13. Reduction of circular RNA Foxo3 promotes prostate cancer progression and chemoresistance to docetaxel.
Shen Z; Zhou L; Zhang C; Xu J
Cancer Lett; 2020 Jan; 468():88-101. PubMed ID: 31593800
[TBL] [Abstract][Full Text] [Related]
14. Targeting Ezh2 could overcome docetaxel resistance in prostate cancer cells.
Qiu X; Wang W; Li B; Cheng B; Lin K; Bai J; Li H; Yang G
BMC Cancer; 2019 Jan; 19(1):27. PubMed ID: 30621625
[TBL] [Abstract][Full Text] [Related]
15. Long non-coding RNA CASC2 regulates Sprouty2 via functioning as a competing endogenous RNA for miR-183 to modulate the sensitivity of prostate cancer cells to docetaxel.
Gao W; Lin S; Cheng C; Zhu A; Hu Y; Shi Z; Zhang X; Hong Z
Arch Biochem Biophys; 2019 Apr; 665():69-78. PubMed ID: 29373811
[TBL] [Abstract][Full Text] [Related]
16. Protein Disulfide Isomerase 4 Drives Docetaxel Resistance in Prostate Cancer.
Qian S; Zhang S; Wu Y; Ding Y; ; Li X
Chemotherapy; 2020; 65(5-6):125-133. PubMed ID: 33238278
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of claspin promotes docetaxel resistance and is associated with prostate-specific antigen recurrence in prostate cancer.
Babasaki T; Sentani K; Sekino Y; Kobayashi G; Thang Pham Q; Katsuya N; Akabane S; Taniyama D; Hayashi T; Shiota M; Oue N; Teishima J; Matsubara A; Yasui W
Cancer Med; 2021 Aug; 10(16):5574-5588. PubMed ID: 34240817
[TBL] [Abstract][Full Text] [Related]
18. The Role of YKL-40 in Predicting Resistance to Docetaxel Chemotherapy in Prostate Cancer.
Darr C; Krafft U; Hadaschik B; Tschirdewahn S; Sevcenco S; Csizmarik A; Nyirady P; Küronya Z; Reis H; Maj-Hes A; Shariat SF; Kramer G; Szarvas T
Urol Int; 2018; 101(1):65-73. PubMed ID: 29949801
[TBL] [Abstract][Full Text] [Related]
19. NPRL2 promotes docetaxel chemoresistance in castration resistant prostate cancer cells by regulating autophagy through the mTOR pathway.
Luo S; Shao L; Chen Z; Hu D; Jiang L; Tang W
Exp Cell Res; 2020 May; 390(2):111981. PubMed ID: 32234375
[TBL] [Abstract][Full Text] [Related]
20. TBK1 Mediates Innate Antiviral Immune Response against Duck Enteritis Virus.
Wang D; Huo H; Werid GM; Ibrahim YM; Tang L; Wang Y; Chen H
Viruses; 2022 May; 14(5):. PubMed ID: 35632751
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
